A detailed history of Israel Englander (Millennium Management LLC) transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 160,123 shares of ATNM stock, worth $225,773. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160,123
Previous 21,038 661.11%
Holding current value
$225,773
Previous $155,000 94.19%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.72 - $8.0 $239,226 - $1.11 Million
139,085 Added 661.11%
160,123 $301,000
Q2 2024

Aug 14, 2024

SELL
$6.56 - $9.89 $304,206 - $458,628
-46,373 Reduced 68.79%
21,038 $155,000
Q1 2024

May 15, 2024

BUY
$5.0 - $9.2 $337,055 - $620,181
67,411 New
67,411 $527,000
Q1 2023

May 15, 2023

BUY
$8.51 - $14.26 $1.51 Million - $2.53 Million
177,392 Added 329.85%
231,172 $2.19 Million
Q4 2022

Feb 14, 2023

BUY
$7.05 - $14.41 $32,655 - $66,747
4,632 Added 9.42%
53,780 $573,000
Q3 2022

Nov 14, 2022

BUY
$4.81 - $8.48 $76,998 - $135,747
16,008 Added 48.3%
49,148 $363,000
Q2 2022

Aug 15, 2022

BUY
$4.71 - $7.11 $156,089 - $235,625
33,140 New
33,140 $159,000
Q1 2021

May 17, 2021

SELL
$7.62 - $9.79 $419,252 - $538,645
-55,020 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$7.8 - $12.64 $429,156 - $695,452
55,020 New
55,020 $429,000

Others Institutions Holding ATNM

About Actinium Pharmaceuticals, Inc.


  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $35.5M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.